209 related articles for article (PubMed ID: 32047944)
61. Correlations of pathological stage and prognosis of NSCLC patients with changes in serum CEA and CYFRA 21-1 and CT characteristics.
Zhao W; Liu Y; Kong F; Li Y
Panminerva Med; 2020 Mar; 62(1):67-69. PubMed ID: 31144789
[No Abstract] [Full Text] [Related]
62. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH
Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727
[TBL] [Abstract][Full Text] [Related]
63. Fluorescence-based immunosensor using three-dimensional CNT network structure for sensitive and reproducible detection of oral squamous cell carcinoma biomarker.
Song CK; Oh E; Kang MS; Shin BS; Han SY; Jung M; Lee ES; Yoon SY; Sung MM; Ng WB; Cho NJ; Lee H
Anal Chim Acta; 2018 Oct; 1027():101-108. PubMed ID: 29866259
[TBL] [Abstract][Full Text] [Related]
64. CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).
Stieber P; Zimmermann A; Reinmiedl J; Müller C; Hoffmann H; Dienemann H
Anticancer Res; 1999; 19(4A):2665-8. PubMed ID: 10470216
[TBL] [Abstract][Full Text] [Related]
65. Novel preparation method of bipedal DNA walker based on hybridization chain reaction for ultrasensitive DNA biosensing.
Feng C; Zhang C; Guo J; Li G; Ye B; Zou L
Anal Chim Acta; 2021 Sep; 1176():338781. PubMed ID: 34399897
[TBL] [Abstract][Full Text] [Related]
66. CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.
Sone K; Oguri T; Nakao M; Kagawa Y; Kurowaka R; Furuta H; Fukuda S; Uemura T; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Maeno K; Ito Y; Sato H; Muramatsu H; Niimi A
Anticancer Res; 2017 Feb; 37(2):935-939. PubMed ID: 28179355
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas.
Karnak D; Ulubay G; Kayacan O; Beder S; Ibis E; Oflaz G
Lung; 2001; 179(1):57-65. PubMed ID: 11479694
[TBL] [Abstract][Full Text] [Related]
68. Ultrasensitive DNA detection based on two-step quantitative amplification on magnetic nanoparticles.
Jin M; Liu X; van den Berg A; Zhou G; Shui L
Nanotechnology; 2016 Aug; 27(33):335102. PubMed ID: 27378514
[TBL] [Abstract][Full Text] [Related]
69. Systematic review of CYFRA 21-1 as a prognostic indicator and its predictive correlation with clinicopathological features in Non-small Cell Lung Cancer: A meta-analysis.
Yu Z; Zhang G; Yang M; Zhang S; Zhao B; Shen G; Chai Y
Oncotarget; 2017 Jan; 8(3):4043-4050. PubMed ID: 28008142
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
[TBL] [Abstract][Full Text] [Related]
71. A microfluidic cathodic photoelectrochemical biosensor chip for the targeted detection of cytokeratin 19 fragments 21-1.
Feng J; Wu T; Cheng Q; Ma H; Ren X; Wang X; Lee JY; Wei Q; Ju H
Lab Chip; 2021 Jan; 21(2):378-384. PubMed ID: 33313636
[TBL] [Abstract][Full Text] [Related]
72. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract][Full Text] [Related]
73. CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.
Ebert W; Muley T
Anticancer Res; 1999; 19(4A):2669-72. PubMed ID: 10470217
[TBL] [Abstract][Full Text] [Related]
74. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-small cell lung cancer.
Kashiwabara K; Nakamura H; Kiguchi T; Yagyu H; Kishi K; Wei BR; Yoneyama K; Matsuoka K
Clin Chim Acta; 1997 Oct; 266(2):149-55. PubMed ID: 9437543
[TBL] [Abstract][Full Text] [Related]
75. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
[TBL] [Abstract][Full Text] [Related]
76. An ultrasensitive electrochemical sensor for phospholipase C
Li X; Meng P; Sun M; Chen Y; Song Z; Wang X; Li N; Sun Y
Analyst; 2023 May; 148(10):2352-2361. PubMed ID: 37098798
[TBL] [Abstract][Full Text] [Related]
77. A novel electrochemical DNA biosensor for transgenic soybean detection based on triple signal amplification.
Chen D; Zhang M; Ma M; Hai H; Li J; Shan Y
Anal Chim Acta; 2019 Oct; 1078():24-31. PubMed ID: 31358225
[TBL] [Abstract][Full Text] [Related]
78. An ultrasensitive fluorescent aptasensor based on truncated aptamer and AGET ATRP for the detection of bisphenol A.
Guo Z; Tang J; Li M; Liu Y; Yang H; Kong J
Anal Bioanal Chem; 2019 Nov; 411(29):7807-7815. PubMed ID: 31745613
[TBL] [Abstract][Full Text] [Related]
79. A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum.
Lin G; Liu T; Hou J; Ren Z; Zhou J; Liang Q; Chen Z; Dong W; Wu Y
J Fluoresc; 2015 Mar; 25(2):361-7. PubMed ID: 25666714
[TBL] [Abstract][Full Text] [Related]
80. Phthalocyanine-BODIPY dye: synthesis, characterization, and utilization for pattern recognition of CYFRA 21-1 in whole blood samples.
Stefan-van Staden RI; Comnea-Stancu IR; Yanık H; Göksel M; Alexandru A; Durmuş M
Anal Bioanal Chem; 2017 Oct; 409(26):6195-6203. PubMed ID: 28852796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
